Pieris pharmaceuticals, inc. (PIRS)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13
Total revenue

13,261

17,270

15,132

5,332

8,545

4,913

8,345

11,691

4,152

18,152

3,927

1,853

1,343

2,726

785

1,072

1,246

2,139

414

160

217

3,275

18

698

1,372

0

0

Operating expenses
Research and development

12,758

14,116

13,211

13,373

14,296

12,998

11,401

9,155

7,936

5,270

6,259

5,396

5,360

6,917

4,621

4,500

3,659

2,942

2,051

1,725

1,524

2,332

926

1,118

1,222

-

-

Professional Fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

-

General and administrative

4,359

4,484

4,835

4,189

4,932

4,563

4,748

4,779

4,352

6,395

2,852

4,348

3,989

2,213

2,341

2,368

1,967

1,762

2,242

1,969

2,394

2,859

933

2,349

821

-

-

Operating Expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

Professional Fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

Bank fees

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Total operating expenses

17,117

18,600

18,046

17,562

19,228

17,561

16,149

13,934

12,288

11,665

9,111

9,744

9,349

9,131

6,962

6,868

5,627

4,704

4,294

3,694

3,918

10,695

1,859

6

1

2

5

Costs and expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,468

2,044

-

-

Loss from operations

-3,856

-1,330

-2,914

-12,230

-10,683

-12,648

-7,804

-2,243

-8,136

6,487

-5,184

-7,891

-8,006

-6,404

-6,177

-5,795

-4,380

-2,565

-3,879

-3,534

-3,701

-1,916

-1,841

-2,769

-671

-2

-5

Interest income

319

382

377

449

506

471

504

662

325

152

0

0

0

-

-

-

-

-180

0

-0

-4

-

-

-

-

-

-

Interest expense, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-181

-

-

-

-

Interest expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

113

109

-

-

Other expense, net

-60

177

-55

23

-171

329

1,147

1,230

-903

995

-1,729

-1,380

12

6

-18

-87

219

7

-1

4

0

0

0

2

0

-

-

Loss before income taxes

-

-

-2,592

-11,758

-

-11,848

-6,153

-351

-8,714

7,634

-6,913

-9,271

-7,994

-6,396

-6,196

-5,883

-4,161

-2,738

-3,881

-3,529

-3,704

-4,166

-2,022

-2,881

-779

-

-

Benefit for income tax

-

-

0

0

-

-164

0

-148

0

143

146

814

0

-

-

-

0

163

40

0

0

0

0

0

-0

-

0

Provision for Income Taxes (Benefit)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

Net Income (Loss) Attributable to Parent

-3,597

-771

-2,592

-11,758

-10,348

-11,684

-6,153

-203

-8,714

7,491

-7,059

-10,085

-7,994

-6,558

-6,196

-5,883

-4,161

-2,901

-3,922

-3,529

-3,704

-4,166

-2,022

-2,881

-779

-2

-5

Other comprehensive income:
Other comprehensive income/(loss) components:
Foreign currency translation

652

-935

1,636

-414

686

650

27

1,266

-747

-1,388

-395

-642

51

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unrealized gain on available-for-sale securities

116

-363

374

-237

240

-579

-506

2,133

-531

-820

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Comprehensive loss

-2,829

-2,069

-582

-12,409

-9,422

-11,613

-6,632

3,196

-9,992

5,283

-7,454

-10,727

-7,943

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Earnings Per Share [Abstract]
Weighted Average Number of Shares Outstanding, Basic

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,000

-

Basic and diluted (USD per share)

-0.07

-0.07

-0.05

-0.24

-0.20

-0.22

-0.11

0.00

-0.17

0.18

-0.16

-0.23

-0.19

-0.17

-0.14

-0.14

-0.10

-0.06

-0.10

-0.12

-0.13

-0.23

-0.17

-0.24

-0.07

0.00

0.00

Weighted average number of common shares outstanding
Basic and diluted (shares)

55,212

53,070

49,353

49,204

50,873

54,206

54,089

53,983

50,046

44,865

44,387

43,408

43,064

43,092

43,063

40,862

39,833

39,957

38,890

29,429

29,292

20,002

11,828

11,828

11,828

-

6,100

Customer revenue
Total revenue

8,885

-

-

-

7,226

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration revenue
Total revenue

4,376

-

-

-

1,319

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-